Pulmonary hypertension, despite advances in treatment, still has a poor prognosis, which is often associated with right heart failure, and for which pulmonary arterial hypertension (PAH) is a severe ...
The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.
Current drugs available for the treatment of primary arterial hypertension ... Serotonin can promote both pulmonary vasoconstriction and pulmonary vascular remodeling and is thought to be involved ...
A new molecular imaging technique— 18 F-FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early ...
The immune protein STAT6 may be a driver of pulmonary hypertension in people with obstructive sleep apnea, a study in mice ...
Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...
Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension. Journal of Nuclear Medicine , 2025; 66 (1): 98 DOI: 10.2967/jnumed.124. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback